CONSEQUENCES OF UNCONTROLLED CALCIUM ENTRY AND ITS PREVENTION WITH CALCIUM-ANTAGONISTS

被引：54

作者：

FLECKENSTEIN, A

FREY, M

FLECKENSTEINGRUN, G

机构：

来源：

关键词：

D O I：

10.1093/eurheartj/4.suppl_H.43

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：43 / 50

页数：8

共 24 条

[1] [Anonymous], CALCIUM ANTAGONISM H
[2] BAJUSZ E, 1963, CONDITIONING FACTORS
[3] BING RJ, 1979, NEW DRUG THERAPY CAL, P27
[4] FLECKENS.A, 1969, PFLUG ARCH EUR J PHY, V307, pR25
[5] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE
FLECKENSTEIN, A
[J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 : 149 - 166
[6] Fleckenstein A, 1974, Recent Adv Stud Cardiac Struct Metab, V4, P563
[7] Fleckenstein A, 1971, Verh Dtsch Ges Kreislaufforsch, V37, P345
[8] Fleckenstein A, 1975, Recent Adv Stud Cardiac Struct Metab, V6, P21
[9] Fleckenstein A, 1973, Recent Adv Stud Cardiac Struct Metab, V2, P455
[10] FLECKENSTEIN A, 1969, INT S DRUGS METABOLI, P11